The Journal of Urology · 1997 · 98 citations · 26 references
MedicineSurgeryUrologyGenitourinary OncologyProstate DiseaseSurgical OncologyProstate CancerProstate PathologyProstate SurgeryRadiation TherapyRadiation Therapy For Prostate DiseaseRadical ProstatectomyBiochemical Response AssessmentIrradiation EffectsPrognosis Of Prostate DiseasePrognostic CriteriaPrognostic VariablesProstate Cancer PrognosisProstate Function
PURPOSE: This study was initiated to determine the efficacy of post-prostatectomy therapeutic radiation for patients with elevated prostate specific antigen (PSA). MATERIALS AND METHODS: A total of 47 patients received 66 Gy. therapeutic irradiation to the prostate bed for a PSA level greater than 0 ng./ml. postoperatively. Univariate and multivariate survival analyses were performed to identify prognostic variables. RESULTS: At a median followup of 36 months (range 18 to 48) 83 and 33% of the patients with PSA 2 ng./ml. or less and 2 ng./ml. or greater, respectively, had no evidence of disease (p = 0.001). Pathological stage and a complete biochemical response (PSA less than 0.05 ng./ml.) were also significant prognostic variables. CONCLUSIONS: Therapeutic irradiation for patients with elevated PSA postoperatively is highly effective. At a median followup of 36 months 64% of the patients remain disease-free.
26
Choice Reviews Online · 1990 · 35.7K citations
Zvi Fuks, Steven A. Leibel, Kent E. Wallner et al. · International Journal of Radiation Oncology*Biology*Physics · 1991 · 451 citations
Staging Errors in Clinically Localized Prostatic Cancer
William J. Catàlona, Alan J. Stein · The Journal of Urology · 1982 · 155 citations